Literature DB >> 16189071

From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias.

Mihai G Netea1, Jos W M Van der Meer, Roger P Sutmuller, Gosse J Adema, Bart-Jan Kullberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189071      PMCID: PMC1251502          DOI: 10.1128/AAC.49.10.3991-3996.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  57 in total

1.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

Review 2.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

3.  Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells.

Authors:  F Re; J L Strominger
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

4.  Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

Authors:  Terry K Means; Eicke Latz; Fumitaka Hayashi; Mandakolathur R Murali; Douglas T Golenbock; Andrew D Luster
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

5.  Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation.

Authors:  Tsuneyasu Kaisho; Katsuaki Hoshino; Tomio Iwabe; Osamu Takeuchi; Teruhito Yasui; Shizuo Akira
Journal:  Int Immunol       Date:  2002-07       Impact factor: 4.823

6.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

7.  Differential induction of interleukin-10 and interleukin-12 in dendritic cells by microbial toll-like receptor activators and skewing of T-cell cytokine profiles.

Authors:  Hai Qi; Timothy L Denning; Lynn Soong
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

Review 8.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

9.  NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.

Authors:  Mihai G Netea; Bart Jan Kullberg; Dirk J de Jong; Barbara Franke; Tom Sprong; Ton H J Naber; Joost P H Drenth; Jos W M Van der Meer
Journal:  Eur J Immunol       Date:  2004-07       Impact factor: 5.532

10.  Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen.

Authors:  Stephanie C Eisenbarth; Damani A Piggott; James W Huleatt; Irene Visintin; Christina A Herrick; Kim Bottomly
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

View more
  56 in total

1.  TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss.

Authors:  Srinivas R Myneni; Rajendra P Settem; Terry D Connell; Achsah D Keegan; Sarah L Gaffen; Ashu Sharma
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

2.  Eradication of the commensal intestinal microflora by oral antimicrobials interferes with the host response to lipopolysaccharide.

Authors:  T Umenai; H Hirai; N Shime; T Nakaya; T Asahara; K Nomoto; M Kita; Y Tanaka; J Imanishi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-20       Impact factor: 3.267

Review 3.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 4.  Vaccines: all things considered.

Authors:  Ken S Rosenthal; Daniel H Zimmerman
Journal:  Clin Vaccine Immunol       Date:  2006-08

5.  Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics.

Authors:  Theo S Plantinga; Wendy W C van Maren; Jeroen van Bergenhenegouwen; Marjolijn Hameetman; Stefan Nierkens; Cor Jacobs; Dirk J de Jong; Leo A B Joosten; Belinda van't Land; Johan Garssen; Gosse J Adema; Mihai G Netea
Journal:  Clin Vaccine Immunol       Date:  2011-02-02

6.  Endocytosis of Mycobacterium tuberculosis heat shock protein 60 is required to induce interleukin-10 production in macrophages.

Authors:  Nazia Parveen; Raja Varman; Shiny Nair; Gobardhan Das; Sudip Ghosh; Sangita Mukhopadhyay
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

7.  Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity.

Authors:  Louis Y A Chai; Frank van de Veerdonk; Renoud J Marijnissen; Shih-Chin Cheng; Ai Leng Khoo; Magda Hectors; Katrien Lagrou; Alieke G Vonk; Johan Maertens; Leo A B Joosten; Bart-Jan Kullberg; Mihai G Netea
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

8.  Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.

Authors:  Henry W Murray; Yunhua Zhang; Yan Zhang; Vanitha S Raman; Steven G Reed; Xiaojing Ma
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

9.  Cold-inducible RNA-binding protein activates splenic T cells during sepsis in a TLR4-dependent manner.

Authors:  Alexandra C Bolognese; Archna Sharma; Weng-Lang Yang; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  Cell Mol Immunol       Date:  2016-08-29       Impact factor: 11.530

10.  Polymer chemistry influences monocytic uptake of polyanhydride nanospheres.

Authors:  Bret D Ulery; Yashdeep Phanse; Avanti Sinha; Michael J Wannemuehler; Balaji Narasimhan; Bryan H Bellaire
Journal:  Pharm Res       Date:  2008-11-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.